These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 9049367)

  • 1. T cell proliferative responses to five human cytomegalovirus proteins in healthy seropositive individuals: implications for vaccine development.
    He H; Rinaldo CR; Morel PA
    J Gen Virol; 1995 Jul; 76 ( Pt 7)():1603-10. PubMed ID: 9049367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of the immune response to human cytomegalovirus glycoprotein B (gB). II. Low gB-specific T and B cell responses are associated with expression of certain HLA-DR alleles.
    Curtsinger JM; Liu YN; Radeke R; Bryon MK; Fuad S; Bach FH; Gehrz RC
    J Gen Virol; 1994 Feb; 75 ( Pt 2)():301-7. PubMed ID: 8113751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The next generation recombinant human cytomegalovirus vaccine candidates-beyond gB.
    Lilja AE; Mason PW
    Vaccine; 2012 Nov; 30(49):6980-90. PubMed ID: 23041121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: reevaluation of prevalence of IE1-specific CTLs.
    Gyulai Z; Endresz V; Burian K; Pincus S; Toldy J; Cox WI; Meric C; Plotkin S; Gönczöl E; Berencsi K
    J Infect Dis; 2000 May; 181(5):1537-46. PubMed ID: 10823751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a conserved HLA-A2-restricted decapeptide from the IE1 protein (pUL123) of human cytomegalovirus.
    Frankenberg N; Pepperl-Klindworth S; Meyer RG; Plachter B
    Virology; 2002 Apr; 295(2):208-16. PubMed ID: 12033779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of a lentiviral vector encoding a HCMV-chimeric IE1-pp65 protein for epitope identification in HLA-Transgenic mice and for ex vivo stimulation and expansion of CD8(+) cytotoxic T cells from human peripheral blood cells.
    Rohrlich PS; Cardinaud S; Lulè J; Montero-Julian FA; Prodhomme V; Firat H; Davignon JL; Perret E; Monseaux S; Necker A; Michelson S; Lemonnier FA; Charneau P; Davrinche C
    Hum Immunol; 2004 May; 65(5):514-22. PubMed ID: 15172452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed type hypersensitivity to human cytomegalovirus.
    Gupta R; Gonczol E; Manning ML; Starr S; Johnson B; Murphy GF; Plotkin SA
    J Med Virol; 1993 Feb; 39(2):109-17. PubMed ID: 8387567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and humoral immune responses to alphavirus replicon vaccines expressing cytomegalovirus pp65, IE1, and gB proteins.
    Reap EA; Dryga SA; Morris J; Rivers B; Norberg PK; Olmsted RA; Chulay JD
    Clin Vaccine Immunol; 2007 Jun; 14(6):748-55. PubMed ID: 17442845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of fourteen individual human cytomegalovirus proteins for helper T cell response.
    Beninga J; Kropff B; Mach M
    J Gen Virol; 1995 Jan; 76 ( Pt 1)():153-60. PubMed ID: 7844526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative T cell responses to four human cytomegalovirus-specific proteins in healthy subjects and solid organ transplant recipients.
    van Zanten J; Harmsen MC; van der Meer P; van der Bij W; van Son WJ; van der Giessen M; Prop J; de Leij L; The TH
    J Infect Dis; 1995 Sep; 172(3):879-82. PubMed ID: 7658088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of the immune response to human cytomegalovirus glycoprotein B. I. Mapping of HLA-restricted helper T cell epitopes on gp93.
    Liu YN; Curtsinger J; Donahue PR; Klaus A; Optiz G; Cooper J; Karr RW; Bach FH; Gehrz RC
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2207-14. PubMed ID: 7691989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-reactive recognition of human and primate cytomegalovirus sequences by human CD4 cytotoxic T lymphocytes specific for glycoprotein B and H.
    Elkington R; Shoukry NH; Walker S; Crough T; Fazou C; Kaur A; Walker CM; Khanna R
    Eur J Immunol; 2004 Nov; 34(11):3216-26. PubMed ID: 15368271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fine specificity of cellular immune responses in humans to human cytomegalovirus immediate-early 1 protein.
    Alp NJ; Allport TD; Van Zanten J; Rodgers B; Sissons JG; Borysiewicz LK
    J Virol; 1991 Sep; 65(9):4812-20. PubMed ID: 1714519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the proliferative T cell response to human cytomegalovirus major immediate-early protein (IE1): phenotype, frequency and variability.
    Davignon JL; Clément D; Alriquet J; Michelson S; Davrinche C
    Scand J Immunol; 1995 Mar; 41(3):247-55. PubMed ID: 7871384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated gA/gB glycoprotein complex of human cytomegalovirus envelope induces humoral and cellular immune-responses in human volunteers.
    Gonczol E; Ianacone J; Ho WZ; Starr S; Meignier B; Plotkin S
    Vaccine; 1990 Apr; 8(2):130-6. PubMed ID: 2159679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection.
    Diamond DJ; York J; Sun JY; Wright CL; Forman SJ
    Blood; 1997 Sep; 90(5):1751-67. PubMed ID: 9292508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of HIV infection on cytomegalovirus-specific immunity: T-cell responses to pp65 and IE1 before and after HAART may reflect altered cytomegalovirus biology.
    Scherrenburg J; Schellens IM; van Baarle D
    Antivir Ther; 2011; 16(4):565-75. PubMed ID: 21685544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cytomegalovirus (HCMV) infection/re-infection: development of a protective HCMV vaccine.
    Gerna G; Lilleri D
    New Microbiol; 2019 Jan; 42(1):1-20. PubMed ID: 30671581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age.
    Adler SP; Starr SE; Plotkin SA; Hempfling SH; Buis J; Manning ML; Best AM
    J Infect Dis; 1995 Jan; 171(1):26-32. PubMed ID: 7798679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response to neutralizing epitope on human cytomegalovirus gylcoprotein B in Japanese: correlation of serologic response with HLA-type.
    Wada K; Mizuno S; Ohta H; Nishiyama Y
    Microbiol Immunol; 1997; 41(10):841-5. PubMed ID: 9403513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.